IP Library Granted Patent US 8,420,813
Granted Patent B2
US 8,420,813 · App. 12/503,373 · Granted Apr 16, 2013

Methods for the synthesis of unsymmetrical cycloalkyl substituted xanthines

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,420,813
App. No.
12/503,373
Granted
Apr 16, 2013
Kind
B2
Abstract

The present invention provides compounds and pharmaceutical compositions that are selective antagonists of A 2B adenosine receptors (ARs). These compounds and compositions are useful as pharmaceutical agents. Also provided are processes for the preparation of the compounds and their intermediates such as: wherein: R 2 and R 21 are defined in the description.

Claims (6)

1. A compound comprising any one of the formulae:

wherein:

R 2 is selected from the group consisting of substituted or unsubstituted halo(C 1-8 )alkyl, (C 3-8 )alkenyl(C 1-8 )alkyl, (C 3-8 )alkynyl(C 1-8 )alkyl,

R 21 and R 22 are each independently selected from the group consisting of hydrogen, or substituted or unsubstituted perhalo(C 1-8 )alkyl, amino, (C 1-8 )alkyl, (C 2-8 )alkenyl, (C 2-8 )alkynyl, (C 3-12 )cycloalkyl, heterocycloalkyl, aryl(C 1-8 )alkyl, heteroaryl, (C 9-12 )bicycloaryl, hetero(C 8-12 )bicycloaryl, aryl, heteroaryl, (C 1-8 )alkoxy, aryloxy, heteroaryloxy; and

X″ is Br, Cl or I; or

a pharmaceutically acceptable salt thereof.

Assignments (10)
MERGER Recorded Jun 26, 2018
From: DOGWOOD PHARMACEUTICALS, INC.
To: ALLERGAN SALES, LLC
Reel/Frame 046208/0691 →
CORRECTIVE ASSIGNMENT TO CORRECT THE EXECUTION DATE OF THE PREVIOUSLY RECORDED ASSIGNMENT FROM DECEMBER 31, 2011 TO MARCH 15, 2013 PREVIOUSLY RECORDED ON REEL 029737 FRAME 0130. ASSIGNOR(S) HEREBY CONFIRMS THE THE EXECUTION DATE OF THE ORIGINAL ASSIGNMENT WAS INCORRECTLY DATED DECEMBER 31, 2011. Recorded Mar 19, 2013
From: FOREST LABORATORIES HOLDINGS LIMITED
To: DOGWOOD PHARMACEUTICALS, INC.
Reel/Frame 030045/0915 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 19, 2013
From: ADENOSINE THERAPEUTICS, L.L.C.
To: PGX HEALTH, LLC
Reel/Frame 030039/0381 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2013
From: FOREST LABORATORIES HOLDINGS LIMITED
To: DOGWOOD PHARMACEUTICALS, INC.
Reel/Frame 029737/0130 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2013
From: CLINICAL DATA, INC.
To: DOGWOOD PHARMACEUTICALS, INC.
Reel/Frame 029736/0958 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2013
From: DOGWOOD PHARMACEUTICALS, INC.
To: FOREST LABORATORIES HOLDINGS LIMITED
Reel/Frame 029737/0043 →
MERGER Recorded Jan 25, 2013
From: TROVIS PHARMACEUTICALS HOLDINGS, INC.
To: CLINICAL DATA, INC.
Reel/Frame 029694/0831 →
MERGER Recorded Jan 24, 2013
From: TROVIS PHARMACEUTICALS LLC
To: TROVIS PHARMACEUTICALS HOLDINGS, INC.
Reel/Frame 029688/0503 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 7, 2011
From: RIEGER, JAYSON M.; THOMPSON, ROBERT D.; WANG, GUOQUAN
To: ADENOSINE THERAPEUTICS, LLC
Reel/Frame 026400/0273 →
CHANGE OF NAME Recorded Jan 28, 2011
From: PGXHEALTH, LLC
To: TROVIS PHARMACEUTICALS, LLC
Reel/Frame 025709/0994 →